Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 620,103 | 576,056 | 549,386 | 545,448 | 580,752 |
| Cost of Goods | 262,250 | 244,459 | 249,025 | 239,805 | 248,313 |
| Gross Profit | 357,853 | 331,597 | 300,361 | 305,643 | 332,439 |
| Operating Expenses | 193,828 | 198,918 | 185,039 | 189,098 | 187,158 |
| Operating Income | 164,275 | 133,138 | 115,347 | 117,350 | 145,594 |
| Interest Expense | 8,186 | 8,386 | 8,560 | 8,453 | 8,457 |
| Other Income | 33 | 40 | 258 | 142 | 172 |
| Pre-tax Income | 156,122 | 124,792 | 107,045 | 109,039 | 137,309 |
| Income Tax | 30,421 | 22,083 | 21,368 | 15,825 | 28,629 |
| Net Income Continuous | 125,701 | 102,709 | 85,677 | 93,214 | 108,680 |
| Minority Interests | -5 | 28 | 39 | -37 | -11 |
| Net Income | $125,706 | $102,681 | $85,638 | $93,251 | $108,691 |
| EPS Basic Total Ops | 1.46 | 1.19 | 1.00 | 1.07 | 1.25 |
| EPS Basic Continuous Ops | 1.46 | 1.19 | 0.99 | 1.07 | 1.25 |
| EPS Diluted Total Ops | 1.43 | 1.17 | 0.97 | 1.05 | 1.23 |
| EPS Diluted Continuous Ops | 1.43 | 1.17 | 0.98 | 1.05 | 1.23 |
| EBITDA(a) | $185,896 | $154,493 | $135,951 | $138,228 | $166,486 |